Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis

Indian Journal of Dermatology

Volumn 57, Issue 2, 2012, Pages 118-122

  Maleki, Masoud ^a   Karimi, Gholamreza ^b   Tafaghodi, Mohsen ^c   Raftari, Somayyeh ^c   Nahidi, Yalda ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Medical Toxicology Research Center   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cutaneous leishmaniasis; glucantime; intralesional injection; treatment; zinc sulfate

Indexed keywords

MEGLUMINE ANTIMONATE; ZINC SULFATE;

ADULT; APPLICATION SITE HYPERPIGMENTATION; ARTICLE; BURNING SENSATION; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; ERYTHEMA; HEALING; HUMAN; INJECTION SITE INFLAMMATION; INJECTION SITE PAIN; INJECTION SITE SWELLING; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SKIN INDURATION; SKIN LEISHMANIASIS; SKIN NECROSIS; TREATMENT RESPONSE;

EID: 84860626859     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.94279     Document Type: Article

References (23)

1. Desjeux P. Leishmaniasis: Current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004;27:305-18. (Pubitemid 38842803)
2. Dowlati Y. Treatment of cutaneous leishmaniasis (Old World). Clin Dermatol 1996;14:513-7. (Pubitemid 26327745)
3. Khatami A, Firooz A, Gorouhi F, Dowlati Y. Treatment of acute Old World cutaneous leishmaniasis: A systematic review of the randomized controlled trials. J Am Acad Dermatol 2007;57:335. e1-29.
4. Lawn SD, Yardley V, Vega-Lopez F, Watson J, Lockwood DN. New World cutaneous leishmaniasis in returned travellers: Treatment failures using intravenous sodium stibogluconate. Trans R Soc Trop Med Hyg 2003;97:443-5. (Pubitemid 39186030)
5. Najim RA, Sharquie KE, Farjou IB. Zinc sulphate in the treatment of cutaneous leishmaniasis: An in vitro and animal study. Mem Inst Oswaldo Cruz 1998;93:831-7. (Pubitemid 128525455)
6. Sharquie KE, Najim RA, Farjou IB, Al-Timimi DJ. Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis. Clin Exp Dermatol 2001;26:21-6. (Pubitemid 32204839)
7. Sharquie KE, Najim RA. Disseminated cutaneous leishmaniasis. Saudi Med J 2004;25:951-4. (Pubitemid 39137160)
8. Sharquie KE, Najim RA, Farjou IB. A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis. Clin Exp Dermatol 1997;22:169-73. (Pubitemid 27513115)
9. Firooz A, Khatami A, Khamesipour A, Nassiri-Kashani M, Behnia F, Nilforoushzadeh M, et al. Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: A randomized, double-blind, controlled clinical trial. J Drugs Dermatol 2005;4:73-9.
10. Sharquie KE, Al-Talib KK, Chu AC. Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony. Br J Dermatol 1988;119:53-7.
11. Faris RM, Jarallah JS, Khoja TA, al-Yamani MJ. Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony. Int J Dermatol 1993;32:610-2. (Pubitemid 23274595)
12. Brody I. Topical treatment of recurrent herpes simplex and postherpetic erythema multiforme with low concentrations of zinc sulphate solution. Br J Dermatol 1981;104:191-4. (Pubitemid 11051211)
13. Najim RA, Sharquie KE, Al-Zubaidy SA. Possible mechanisms of action of the compounds injected intralesionally in the treatment of cutaneous leishmaniasis, in addition to their direct effects on the parasites. Ann Trop Med Parasitol 2006;100:33-8. (Pubitemid 43139630)
14. Sharquie KE, Al-Azzawi KE. Intralesional therapy of cutaneous leishmaniasis with 2% zinc sulphate solution. J Pan-Arab League. Dermatologists 1996;7:41-6.
15. Wintergerst ES, Maggini S, Hornig DH. Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab 2007;51:301-23. (Pubitemid 47442973)
16. Prasad AS. Impact of the discovery of human zinc deficiency on health. J Am Coll Nutr 2009;28:257-65.
17. Prasad AS. Zinc: Role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 2009;12:646-52.
18. Puentes F, Guzmán F, Marín V, Alonso C, Patarroyo ME, Moreno A. Leishmania: Fine mapping of the Leishmanolysin molecule's conserved core domains involved in binding and internalization. Exp Parasitol 1999;93:7-22. (Pubitemid 29408982)
19. Kocyigit A, Erel O, Gurel MS, Avci S, Aktepe N. Alterations of serum selenium, zinc, copper, and iron concentrations and some related antioxidant enzyme activities in patients with cutaneous leishmaniasis. Biol Trace Elem Res 1998;65:271-81.
20. Kocyigit A, Gur S, Erel O, Gurel MS. Associations among plasma selenium, zinc, copper, and iron concentrations and immunoregulatory cytokine levels in patients with cutaneous leishmaniasis. Biol Trace Elem Res 2002;90:47-55. (Pubitemid 36110741)
21. Pasa S, Kargin F, Bildik A, Seyrek K, Ozbel Y, Ozensoy S. Serum and hair levels of zinc and other elements in dogs with visceral leishmaniasis. Biol Trace Elem Res 2003;94:141-7. (Pubitemid 37152191)
22. Kocyigit A, Erel O, Seyrek A, Gurel MS, Aktepe N, Avci S, et al. Effects of antimonial therapy on serum zinc, copper and iron concentrations in patients with cutaneous Leishmaniasis in Turkey. J Egypt Soc Parasitol 1998;28:133-42.
23. Iraji F, Vali A, Asilian A, Shahtalebi MA, Momeni AZ. Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis. Dermatology 2004;209:46-9. (Pubitemid 39179105)